Sustainable

business

solutions

Learn more at Pharmapack

booth B72, Feb 5-6 Paris, France

NOLATO GOES GREEN

Sustainable and Renewable packaging materials

Sustainability has always been an integral part of the strategy for the Nolato group. Our aim is to be in the lead and we are constantly seeking new sustainable business solutions and to contribute to a better environment. Nolato is now introducing bio-based Polyet-hylene packaging produced from sugarcane – renewable, sustainable and ECO friendly!

Several product ranges from Nolato Jaycare and Nolato Cerbo have been validated with the alternative “green” Polyethylene and all product properties - mechanical, functional, recycling - are identical to those of petrochemical resins. 
The difference is in the carbon footprint, which is significantly lower for bioplastics in comparison with oil based raw materials.
Contact us and we will show you our new Green product alternatives to you.

Product Performance

PROPERTY

REQUIREMENT IN STANDARD1)

NORMAL POLYMER

SUSTAINABLE POLYMER

Tightness WVP2)avg

Tightness WVPmax

Light transmission3)

30 mg/day/L 
20 mg/day/L 
<10% for 290-450 nm

<3

<4

<10

<3

<4

<10

Notes:

1) According to USP 671 standards

2) Tightness - average values of Cerbo Classic 200ml with SC Light 42 cap and Cerbo Threasy

3) Light transmission - average values of Cerbo Classic (200ml) and Cerbo Threasy bottles

For further information, contact:
E-mail: nolatocerbo@nolato.com  /  www.nolato.com/pharma-packaging

Go to article: Home | EDS: Treating a medical zebraGo to article: Scandinavian Health LtdGo to article: EditorialGo to article: Emirates SkyCargoGo to article: ContentsGo to article: Nolato Company Insight Go to article: NolatoGo to article: NewsGo to article: The pharma industry briefingGo to article: Subcuject Company Insight Go to article: SubcujectGo to article: Horizon 2020: a look back at flagship EU pharma projectsGo to article: SanofiGo to article: Sky high: should US drug prices fall in-line with the rest of the world?Go to article: Nipro PharmapackagingGo to article: Q&A: talking drug quality with Valisure, the first analytical pharmacyGo to article: NemeraGo to article: What does ‘ageing’ mean when it comes to drug development? Go to article: Swiss WorldCargoGo to article: Manufacturing medicines in space: how astronauts will make their own drugs Go to article: MimotopesGo to article: Aducanumab’s surprising revival: how an Alzheimer’s drug came back from the deadGo to article: Molnar Company Insight Go to article: Molnar-InstituteGo to article: Ehlers-Danlos syndrome: The zebra in the roomGo to article: KugelmeiersGo to article: Stop ignoring the two billion: pharma’s role in expanding access to medicineGo to article: SkyepharmaGo to article: IDMP: turning attention to patient benefitsGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next issue